Fig. 4: Overall survival of DLBCL patients from high-level MYC amplification cohort compared to DLBCL patients from the MER cohort.
From: High level MYC amplification in B-cell lymphomas: is it a marker of aggressive disease?
a High-level MYC amplification without DHL/THL versus no MYC abnormalities on FISH and MYC rearrangement alone (single hit) DLBCL cases from the MER. b High-level MYC amplification with DHL/THL versus DHL/THL cases from the MER.
